A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults.

I Sagara, RD Ellis, A Dicko, MB Niambele, B Kamate, O Guindo, MS Sissoko, MP Fay, MA Guindo, O Kante, R Saye, K Miura, C Long, GE Mullen, M Pierce, LB Martin, K Rausch, A Dolo, DA Diallo, LH MillerOK Doumbo

Research output: Contribution to journalArticlepeer-review

68 Citations (Scopus)
Original languageEnglish
Pages (from-to)7292 - 7298
Number of pages7
JournalVaccine
Volume27
Issue number52
Publication statusPublished - 9 Dec 2009

Cite this